Skip to main content
Clinical Trials/JPRN-UMIN000029351
JPRN-UMIN000029351Recruiting未知

Multicenter retrospective study of efficacy of the combination of cetuximab and paclitaxel in patients with recurrent and/or metastatic oral squamous cell carcinoma - Retrospective study of the efficacy of the combination of cetuximab and paclitaxel

agasaki university0 sites50 target enrollmentStarted: September 29, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Before December 2012 there is a treatment history with Cetuximab. 2. Besides oral cancer, it has serious complications affecting life prognosis 3. Other patients whose research managers judged inappropriate as subjects.

Investigators

Sponsor
agasaki university

Similar Trials

Multicenter retrospective study of... | Clinical Trial